Our client’s requirement
A biotech firm based on the US East Coast partnered with Excelra to revolutionize prostate cancer screening. The objective was to enhance the reliability of screening, reducing unnecessary biopsies and associated risks such as bleeding, infection, and additional healthcare costs.
Learn more about our Scientific Informatics Solutions and Bioinformatics Services for accelerating oncology research.
Our approach
We implemented AI/ML techniques leveraging a new semen sample analysis containing diverse biomarkers. Our team utilized ensemble learning methodologies, including Deep Neural Networks and Gradient Boosted Decision Trees, to build a robust diagnostic framework.
Explore our expertise in Application Development for Drug Discovery and Data Curation that power AI-driven clinical diagnostics.
